Ticker League

Free Cash Flow for Alnylam Pharmaceuticals (ALNY)

As of · Reported

Metric

Latest period

$641.34M

YoY change

-1192.7%

5Y CAGR

—

Peak year (2025)

$465.38M

Free Cash Flow history chart for Alnylam Pharmaceuticals (ALNY) from 2002 to 2025

Latest: $465.38M

Free Cash Flow growth chart for Alnylam Pharmaceuticals (ALNY) from 2002 to 2025

Latest: -1192.7%

Free Cash Flow history table for Alnylam Pharmaceuticals (ALNY) from 2002 to 2025

  • 2025$465.38M-1192.7%
  • 2024−$42.59M-201.5%
  • 2023$41.95M-106.8%
  • 2022−$613.33M-14.6%
  • 2021−$718.07M+4.8%
  • 2020−$685.32M+63.7%
  • 2019−$418.58M-39.3%
  • 2018−$689.50M+41.6%
  • 2017−$487.00M+30.8%
  • 2016−$372.26M+84.2%
  • 2015−$202.09M+15.7%
  • 2014−$174.60M+140.3%
  • 2013−$72.66M-41.4%
  • 2012−$123.96M+40.3%
  • 2011−$88.36M-0.8%
  • 2010−$89.07M+15.5%
  • 2009−$77.09M-240.9%
  • 2008$54.73M-71.0%
  • 2007$188.73M-737.3%
  • 2006−$29.62M+60.7%
  • 2005−$18.43M-35.5%
  • 2004−$28.58M+79.2%
  • 2003−$15.95M+766.7%
  • 2002−$1.84M—

Free Cash Flow values are taken from Alnylam Pharmaceuticals's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Free Cash Flow at Alnylam Pharmaceuticals (ALNY)

Free Cash Flow for Alnylam Pharmaceuticals (ALNY): headline value $641.34M · YoY -1192.7%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Alnylam Pharmaceuticals (ALNY) most recent annual free cash flow stands at $465.38M (2025) – plunged 1192.7% year-over-year.

2025 marks the peak free cash flow at $465.38M, with the historical low of −$718.07M recorded in 2021.

Alnylam Pharmaceuticals Free Cash Flow by Year

Alnylam Pharmaceuticals Free Cash Flow 2025: $465.38M

Alnylam Pharmaceuticals posted free cash flow of $465.38M in 2025, plunged 1192.7% below 2024. This figure represents the highest annual value in the available history.

Alnylam Pharmaceuticals Free Cash Flow 2024: −$42.59M

In 2024, Alnylam Pharmaceuticals reported free cash flow of −$42.59M, plunged 201.5% below 2023.

Alnylam Pharmaceuticals Free Cash Flow 2023: $41.95M

Alnylam Pharmaceuticals free cash flow in 2023 was $41.95M, plunged 106.8% below 2022.

Alnylam Pharmaceuticals Free Cash Flow 2022: −$613.33M

2022's free cash flow for Alnylam Pharmaceuticals came in at −$613.33M, declined 14.6% below 2021.

Alnylam Pharmaceuticals Free Cash Flow 2021: −$718.07M

Alnylam Pharmaceuticals free cash flow in 2021 was −$718.07M.

See more financial history for Alnylam Pharmaceuticals (ALNY).

Sector peers by Free Cash Flow

Healthcare peers of Alnylam Pharmaceuticals (ALNY), ranked by their latest free cash flow

Frequently asked questions

Alnylam Pharmaceuticals (ALNY) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Capital Return